Genetic predisposition and hematopoietic malignancies in children: Primary immunodeficiency

European Journal of Medical Genetics

Volumn 59, Issue 12, 2016, Pages 647-653

  van der Werff ten Bosch, Jutte ^a   van den Akker, Machiel ^a,b  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^b Paola Kinderziekenhuis Antwerpen   (Belgium)

Author keywords

Children; Leukemia; Lymphoma; Primary immuno deficiency

Indexed keywords

TRANSCRIPTION FACTOR GATA 2;

ARTICLE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CANCER INCIDENCE; CHILDHOOD CANCER; CHROMOSOME BREAKAGE; GENETIC PREDISPOSITION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPER IGE SYNDROME; INFECTION RISK; ONCOLOGIST; SEVERE CONGENITAL NEUTROPENIA; VIRUS INFECTION; CHILD; COMPLICATION; GENETICS; HEMATOLOGIC NEOPLASMS; IMMUNOLOGIC DEFICIENCY SYNDROMES; PATHOLOGY; RISK FACTOR;

CHILD; GENETIC PREDISPOSITION TO DISEASE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; RISK FACTORS;

EID: 84961223741     PISSN: 17697212     EISSN: 18780849     Source Type: Journal    
DOI: 10.1016/j.ejmg.2016.03.001     Document Type: Article

References (104)

1. Abu-Arja, R.F.1, Chernin, L.R., Abusin, G., et al. Successful hematopoietic cell transplantation in a patient with X-linked agammaglobulinemia and acute myeloid leukemia. Pediatr. Blood Cancer 62:9 (2015 Sep), 1674–1676.
2. Aziz Bousfiha, A., Jeddane, L., Ailal, F., et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J. Clin. Immunol. 33 (2013), 1–7.
3. Beekman, R., Valkhof, M.G., Sanders, M.A., et al. Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia. Blood 119:22 (2012 May 31), 5071–5077.
4. Beltinger, C., Kurz, E., Böhler, T., et al. CD95 (APO-1/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood 91:10 (1998 May 15), 3943–3951.
5. Bigley, V., Haniffa, M., Doulatov, S., et al. The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency. J. Exp. Med. 208:2 (2011), 227–234.
6. Biron, C.A., Byron, K.S., Sullivan, J.L., Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:26 (1989), 1731–1735.
7. Boyle, J.M., Buckley, R.H., Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J. Clin. Immunol., 27(497–502), 2007.
8. Brandau, O., Schuster, V., Weiss, M., Epstein-Barr virus-negative boys with non-Hodgkin lymphoma are mutated in the SH2D1A gene, as are patients with X-linked lymphoproliferative disease (XLP). Hum. Mol. Genet. 8:13 (1999 Dec), 2407–2413.
9. Buchbinder, D., Nugent, D.J., Fillipovich, A.H., Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl. Clin. Genet. 7 (2014 Apr 3), 55–66.
10. Buck, D., Malivert, L., de Chasseval, R., et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124:2 (2006 Jan 27), 287–299.
11. Carlsson, G., Fasth, A., Berglöf, E., et al. Incidence of severe congenital neutropenia in Sweden and risk of evolution to myelodysplastic syndrome/leukaemia. Br. J. Haematol. 158:3 (2012 Aug), 363–369.
12. Chandesris, M.O., Melki, I., Natividad, A., et al. Autosomal dominant STAT3 deficiency and hyper-IgE syndrome: molecular, cellular, and clinical features from a French national survey. Medicine (Baltimore) 91:4 (2012 Jul), e1–19.
13. Chistiakov, D.A., Voronova, N.V., Chistiakov, A.P., Ligase IV syndrome. Eur. J. Med. Genet. 52:6 (2009 Nov-Dec), 373–378.
14. Chrzanowska, K.H., Gregorek, H., Dembowska-Bagińska, B., et al. Nijmegen breakage syndrome (NBS). Orphanet J. Rare Dis., 7, 2012 Feb 28, 13.
15. Coffey, A.J., Brooksbank, R.A., Brandau, O., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:2 (1998 Oct), 129–135.
16. Collin, M., Dickinson, R., Bigley, V., Haematopoietic and immune defects associated with GATA2 mutation. Br. J. Haematol. 169:2 (2015 Apr), 173–187.
17. Cotelingam, J.D., Witebsky, F.G., Hsu, S.M., et al. Malignant lymphoma in patients with the Wiskott-Aldrich syndrome. Cancer Invest. 3:6 (1985), 515–522.
18. Cunningham-Rundles, C., How I treat common variable immune deficiency. Blood 116 (2010), 7–15.
19. Davis, S.D., Schaller, J., Wedgwood, R., Job's Syndrome. Recurrent, “cold”, staphylococcal abscesses. Lancet 1:7445 (1966 May 7), 1013–1015.
20. Dickinson RE, Griffin H, Bigley V, et al. Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency.
21. Engelhardt, K.R., McGhee, S., Winkler, S., et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J. Allergy Clin. Immunol., 124(6), 2009 Dec 1289–302.e4.
22. Finn, O.J., Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann. Oncol., 23(Suppl. 8), 2012 Sep viii6–9.
23. Fisher, G.H., Rosenberg, F.J., Straus, S.E., et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:6 (1995 Jun 16), 935–946.
24. Freeman, A.F., Holland, S.M., Clinical manifestations of hyper IgE syndromes. Dis. Markers 29 (2010), 123–130.
25. Gangemi, S., Allegra, A., Musolino, C., Lymphoproliferative disease and cancer among patients with common variable immunodeficiency. Leuk. Res. 39:4 (2015 Apr), 389–396.
26. Gathmann, B., Mahlaoui, N., Gérard, L., et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 134:1 (2014 Jul), 116–126.
27. Germeshausen, M., Ballmaier, M., Welte, K., Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood 109:1 (2007), 93–99.
28. Goodwin, E.C., DiMaio, D., Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways. Proc. Natl. Acad. Sci. U. S. A. 97:23 (2000 Nov 7), 12513–12518.
29. Gorin, L.J., Jeha, S.C., Sullivan, M.P., et al. Burkitt's lymphoma developing in a 7-year-old boy with hyper-IgE syndrome. J. Allergy Clin. Immunol. 83 (1989), 5–10.
30. Groopman, J.E., Broder, S., Cancers in AIDS and other immunodeficiency states. DeVita, V.T., Hellman, S., Rosenberg, S.A., (eds.) Cancer: Principles and Practice of Oncology, third ed., 1989, JB Lippincott, Philadelphia, 1953–1970.
31. Hahn, C.N., Chong, C.E., Carmichael, C.L., et al. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat. Genet. 43:10 (2011), 1012–1017.
32. Hermans, M.H., Antonissen, C., Ward, A.C., et al. Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J. Exp. Med. 189:4 (1999), 683–692.
33. Horwitz, M., Benson, K.F., Person, R.E., et al. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat. Genet. 23 (1999), 433–436.
34. Hoshino, A., Okuno, Y., Migita, M., et al. X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia. J. Clin. Immunol. 35:2 (2015 Feb), 108–111.
35. Hsu, J.L., Glaser, S.L., Epstein–Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol./Hematol. 34 (2000), 27–53.
36. Hsu, A.P., Sampaio, E.P., Khan, J., et al. Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. Blood 118:10 (2011), 2653–2655.
37. Jackson, C.E., Fischer, R.E., Hsu, A.P., et al. Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am. J. Hum. Genet. 64:4 (1999 Apr), 1002–1014.
38. Jonkman-Berk, B.M., van den Berg, J.M., Ten Berge, I.J., et al. Primary immunodeficiencies in the Netherlands: national patient data demonstrate the increased risk of malignancy. Clin. Immunol. 156:2 (2015 Feb), 154–162.
39. Juncà, J., Millá, F., Xicoy, B., et al. Pro-B acute lymphoblastic leukemia in a patient with severe congenital neutropenia: an unusual form of malignant evolution. Leuk. Lymphoma 54:10 (2013 Oct), 2325–2327.
40. Kashef, M.A., Kashef, S., Handjani, F., Karimi, M., Hodgkin lymphoma developing in a 4.5-year-old girl with hyper-IgE syndrome. Pediatr. Hematol. Oncol. 23:1 (2006 Jan-Feb), 59–63.
41. Kersey, J.H., Shapiro, R.S., Filipovich, A.H., Relationship of immunodeficiency to lymphoid malignancy. Pediatr. Infect. Dis. J. 7:Suppl. 5 (1988), S10–S12.
42. Kostmann, R., Infantile genetic agranulocytosis; agranulocytosis infantilis hereditaria. Acta Paediatr. Suppl. 45 (1956), 1–78.
43. Kreins, A.Y., Ciancanelli, M.J., Okada, S., et al. Human TYK2 deficiency: mycobacterial and viral infections without hyper-IgE syndrome. J. Exp. Med. 212:10 (2015 Sep 21), 1641–1662.
44. Li, F.Y., Chaigne-Delalande, B., Kanellopoulou, C., et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature 475:7357 (2011 Jul 27), 471–476.
45. Lin, S.J., Huang, J.L., Hsieh, K.H., Hodgkin's disease in a child with hyperimmunoglobulin E syndrome. Pediatr. Hematol. Oncol. 15:5 (1998 Sep–Oct), 451–454.
46. Mace, E.M., Hsu, A.P., Monaco-Shawver, L., et al. Mutations in GATA2 cause human NK cell deficiency with specific loss of the CD56(bright) subset. Blood 121:14 (2013), 2669–2677.
47. Makaryan, V., Zeidler, C., Bolyard, A.A., et al. The diversity of mutations and clinical outcomes for ELANE-associated neutropenia. Curr. Opin. Hematol. 22:1 (2015 Jan), 3–11.
48. Mäkitie, O., Pukkala, E., Teppo, L., et al. Increased incidence of cancer in patients with cartilage-hair hypoplasia. J. Pediatr. 134:3 (1999 Mar), 315–318.
49. Mansour, S., Connell, F., Steward, C., et al., Lymphoedema Research Consortium. Emberger syndrome-primary lymphedema with myelodysplasia: report of seven new cases. Am. J. Med. Genet. A 152A:9 (2010), 2287–2296.
50. McClain, K.L., Leach, C.T., Jenson, H.B., et al. Association of Epstein–Barr virus with leiomyosarcomas in children with AIDS. New Engl. J. Med. 332 (1995), 12–18.
51. McFadden, K., Luftig, M.A., Interplay between DNA tumor viruses and the host DNA damage response. Curr. Top. Microbiol. Immunol. 371 (2013), 229–257.
52. McKusick, V.A., Eldridge, R., Hostetler, J.A., et al. Dwarfism in the amish II Cartilage-hair hypoplasia. Bull. Johns Hopkins Hosp. 116 (1965), 285–326.
53. Milner, J.D., Brenchley, J.M., Laurence, A., et al. Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature, 452(7188), 2008 Apr 10, 773.
54. Moore, P.S., Boshoff, C., Weiss, R.A., et al. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274:5293 (1996 Dec 6), 1739–1744.
55. Moraes, M.C., Neto, J.B., Menck, C.F., DNA repair mechanisms protect our genome from carcinogenesis. Front. Biosci. (Landmark Ed) 17 (2012 Jan 1), 1362–1388.
56. Mosseri, R., Finkelstein, Y., Monselize, Y., et al. Large T-cell lymphoma in a 13-year-old girl with hyperimmunoglobulinemia E syndrome. Pediatr. Allergy Immunol. 13:2 (2002 Apr), 143–146.
57. Notarangelo, L.D., PIDs and cancer: an evolving story. Blood, 116(8), August 26, 2010.
58. Ohshima, H., Tatemichi, M., Sawa, T., Chemical basis of inflammation-induced carcinogenesis. Arch. Biochem. Biophys. 417 (2003), 3–11.
59. Oliveira, J.B., Bidère, N., Niemela, J.E., et al. NRAS mutation causes a human autoimmune lymphoproliferative syndrome. Proc. Natl. Acad. Sci. U. S. A. 104:21 (2007 May 22), 8953–8958.
60. Oliveira, J.B., Bleesing, J.J., Dianzani, U., et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 116:14 (2010 Oct 7), e35–e40.
61. Ostergaard, P., Simpson, M.A., Connell, F.C., et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat. Genet. 43:10 (2011), 929–931.
62. Pasquet, M., Bellanné-Chantelot, C., Tavitian, S., et al. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121:5 (2013), 822–829.
63. Plebani, A., Soresina, A., Rondelli, R., et al., Italian Pediatric Group for XLA-AIEOP. Clinical, immunological, and molecular analysis in a large cohort of patients with X-linked agammaglobulinemia: an Italian multicenter study. Clin. Immunol. 104:3 (2002 Sep), 221–230.
64. Pollard, J.M., Gatti, R.A., Clinical radiation sensitivity with DNA repair disorders: an overview. Int. J. Radiat. Oncol. Biol. Phys. 74:5 (2009 Aug 1), 1323–1331.
65. Price, S., Shaw, P.A., Seitz, A., et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood 123:13 (2014 Mar 27), 1989–1999.
66. Rezaei, N., Mahmoudi, E., Aghamohammadi, A., et al. X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. Br. J. Haematol. 152:1 (2011 Jan), 13–30.
67. Ridanpaa, M., Sistonen, P., Rockas, S., et al. Worldwide mutation spectrum in cartilage-hair hypoplasia: ancient founder origin of the major70A→G mutation of the untranslated RMRP. Eur. J. Hum. Genet. 10:7 (2002), 439–447.
68. Ries, L.M., Smith, J. Gurney, Cancer incidence and Survival Among Children and Adolescents: United States SEER Program 1975–1995. 1999, National Cancer Institute SEER Program.
69. Rieux-Laucat, F., Le Deist, F., Hivroz, C., et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:5215 (1995 Jun 2), 1347–1349.
70. Rigaud, S., Fondanèche, M.C., Lambert, N., et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444:7115 (2006 Nov 2), 110–114.
71. Rosenberg, P.S., Alter, B.P., Bolyard, A.A., et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107 (2006), 4628–4635.
72. Rosenberg, P.S., Alter, B.P., Link, D.C., et al. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br. J. Haematol. 140 (2008), 210–213.
73. Sandlund, J.T., Shurtleff, S.A., Onciu, M., et al. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms. Pediatr. Blood Cancer 60:9 (2013 Sep), E85–E87.
74. Sandoval, C., Dunbar, J., Ozkaynak, M., et al. Osteosarcoma following growth hormone therapy in recurrent acute lymphoblastic leukemia and Rapadilino syndrome. Pediatr. Hematol. Oncol. 29:3 (2012 Apr), 270–271.
75. Sanz MM and German J. Bloom's Syndrome http://www.ncbi.nlm.nih.gov/books/NBK1398/#bloom.REF.german.2002.1.
76. Schwartz, C.L., Hobbie, W.L., Constine, L.S., et al. (eds.) Survivors of Childhood Cancer: Assessment and Management, 1994, Mosby, St. Louis, Mo.
77. Seidemann, K., Henze, G., Beck, J.D., et al. Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): experience from the BFM trials. Ann. Oncol. 11:Suppl. I (2000), S141–S145.
78. Shiba, N., Funato, M., Ohki, K., et al. Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia. Br. J. Haematol. 164:1 (2014 Jan), 142–145.
79. Siitonen, H.A., Sotkasiira, J., Biervliet, M., et al. The mutation spectrum in RECQL4 diseases. Eur. J. Hum. Genet. 17:2 (2009 Feb), 151–158.
80. Skokowa, J., Steinemann, D., Katsman-Kuipers, J.E., et al. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood 123:14 (2014 Apr 3), 2229–2237.
81. Sowerwine, K.J., Holland, S.M., Freeman, A.F., Hyper-IgE syndrome update. Ann. N. Y. Acad. Sci. 1250 (2012), 25–32.
82. Spinner, M.A., Sanchez, L.A., Hsu, A.P., et al. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. Blood 123:6 (2014 Feb 6), 809–821.
83. Stiller, C.A., Epidemiology and genetics of childhood cancer. Oncogene 23 (2004), 6429–6444.
84. Straus, S.E., Jaffe, E.S., Puck, J.M., et al. The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:1 (2001 Jul 1), 194–200.
85. Sullivan, K.E., Mullen, C.A., Blaese, R.M., et al. A mutliinstitutional survey of the Wiskott-Aldrich syndrome. J. Pediatr. 125:6 Pt 1 (1994), 876–885.
86. Sullivan, S.G., Hussain, R., Glasson, E.J., et al. The profile and incidence of cancer in Down syndrome. J. Intellect. Disabil. Res. 51:Pt 3 (2007 Mar), 228–231.
87. Takagi, M., Shinoda, K., Piao, J., et al. Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood 117:10 (2011 Mar 10), 2887–2890.
88. Taylor, A.M., Metcalfe, J.A., Thick, J., et al. Leukemia and lymphoma in ataxia telangiectasia. Blood 87:2 (1996 Jan 15), 423–438.
89. Torgovnick, A., Schumacher, B., DNA repair mechanisms in cancer development and therapy. Front. Genet., 6, 2015 Apr 23, 157.
90. Tsai, F.Y., Orkin, S.H., Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89:10 (1997 May 15), 3636–3643.
91. Van Der Bruggen, P., Zhang, Y., Chaux, P., et al. Tumor-specific shared antigenic peptides recognized by human T cells. Immunol. Rev. 188 (2002), 51–64.
92. Vandenberghe, P., Beel, K., Severe congenital neutropenia, a genetically heterogeneous disease group with an increased risk of AML/MDS. Pediatr. Rep., 3(Suppl. 2), 2011 Jun 22, e9.
93. Vinh, D.C., Patel, S.Y., Uzel, G., et al. Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia. Blood 115:8 (2010), 1519–1529.
94. Vollebregt, M.M., Malfroot, A., De Raedemaecker, M., et al. Immunodeficiency in a child with Rapadilino syndrome: a case report and review of the literature. Case Rep. Immunol., 2015, 2015, 137368.
95. Watford, W.T., O'Shea, J.J., Human tyk2 kinase deficiency: another primary immunodeficiency syndrome. Immunity 25:5 (2006 Nov), 695–697.
96. Wehr, C., Kivioja, T., Schmitt, C., et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111:1 (2008 Jan 1), 77–85.
97. Winkelstein, J.A., Marino, M.C., Lederman, H.M., et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 85:4 (2006 Jul), 193–202.
98. Wu, J., Wilson, J., He, J., et al. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferativedisease. J. Clin. Invest. 98:5 (1996 Sep 1), 1107–1113.
99. Yohshimi, A., Kamachi, Y., Imai, Y., et al. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukemia. Pediatr. Blood Cancer 60:5 (2013), 836–841.
100. Zhang, Q., Davis, J.C., Lamborn, I.T., et al. Combined immunodeficiency associated with DOCK8 mutations. N. Engl. J. Med. 361:21 (2009 Nov 19), 2046–2055.
101. Zhang, Q., Davis, J.C., Dove, C.G., et al. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Dis. Markers 29 (2010), 131–139.
102. Zils, K., Klingebiel, T., Behnisch, W., et al. Osteosarcoma in patients with Rothmund-Thomson syndrome. Pediatr. Hematol. Oncol. 32:1 (2015 Feb), 32–40.
103. Zuo, J., Currin, A., Griffin, B.D., Shannon-Lowe, C., et al. The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradation. PLoS Pathog., 5(1), 2009 Jan, e1000255.
104. zur Hausen, Harald, The search for infectious causes of human cancers: where and why (nobel lecture). Angew. Chem. Int. Ed. 48 (2009), 5798–5808.